Cite
HARVARD Citation
Poznanski, S. et al. (2022). Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity. European respiratory journal. 59 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Poznanski, S. et al. (2022). Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity. European respiratory journal. 59 (4), p. . [Online].